These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23952187)

  • 1. The impact of long-acting medications on attention-deficit/hyperactivity disorder treatment disparities.
    Saloner B; Fullerton C; McGuire T
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):401-9. PubMed ID: 23952187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receipt of Medication and Behavioral Therapy Among a National Sample of School-Age Children Diagnosed With Attention-Deficit/Hyperactivity Disorder.
    Walls M; Allen CG; Cabral H; Kazis LE; Bair-Merritt M
    Acad Pediatr; 2018 Apr; 18(3):256-265. PubMed ID: 29061327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and ethnic disparities in ADHD diagnosis from kindergarten to eighth grade.
    Morgan PL; Staff J; Hillemeier MM; Farkas G; Maczuga S
    Pediatrics; 2013 Jul; 132(1):85-93. PubMed ID: 23796743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial/ethnic disparities in ADHD diagnosis by kindergarten entry.
    Morgan PL; Hillemeier MM; Farkas G; Maczuga S
    J Child Psychol Psychiatry; 2014 Aug; 55(8):905-13. PubMed ID: 24456307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
    Barner JC; Khoza S; Oladapo A
    Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Palli SR; Kamble PS; Chen H; Aparasu RR
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):139-48. PubMed ID: 22364400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial-Ethnic Differences in Patterns of Discontinuous Medication Treatment Among Medicaid-Insured Youths With ADHD.
    Ji X; Druss BG; Lally C; Cummings JR
    Psychiatr Serv; 2018 Mar; 69(3):322-331. PubMed ID: 29191137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial Disparities in Diagnosis of Attention-Deficit/Hyperactivity Disorder in a US National Birth Cohort.
    Shi Y; Hunter Guevara LR; Dykhoff HJ; Sangaralingham LR; Phelan S; Zaccariello MJ; Warner DO
    JAMA Netw Open; 2021 Mar; 4(3):e210321. PubMed ID: 33646315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
    Christensen L; Sasané R; Hodgkins P; Harley C; Tetali S
    Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program.
    Lawson KA; Johnsrud M; Hodgkins P; Sasané R; Crismon ML
    Clin Ther; 2012 Apr; 34(4):944-956.e4. PubMed ID: 22444786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
    Bhang SY; Hwang JW; Kwak YS; Joung YS; Lee S; Kim B; Sohn SH; Chung US; Yang J; Hong M; Bahn GH; Choi HY; Oh IH; Lee YJ
    J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults.
    Setyawan J; Hodgkins P; Guérin A; Gauthier G; Cloutier M; Wu E; Erder MH
    J Med Econ; 2013 Oct; 16(10):1203-15. PubMed ID: 23937642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
    Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic Disparities in School-Based Behavioral Health Service Use for Children With Psychiatric Disorders.
    Locke J; Kang-Yi CD; Pellecchia M; Marcus S; Hadley T; Mandell DS
    J Sch Health; 2017 Jan; 87(1):47-54. PubMed ID: 27917490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to Surgery and Anesthesia in Early Childhood and Subsequent Use of Attention Deficit Hyperactivity Disorder Medications.
    Ing C; Ma X; Sun M; Lu Y; Wall MM; Olfson M; Li G
    Anesth Analg; 2020 Sep; 131(3):723-733. PubMed ID: 31923004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth.
    Yee LM; Liu LY; Sakowicz A; Bolden JR; Miller ES
    Am J Obstet Gynecol; 2016 Mar; 214(3):374.e1-6. PubMed ID: 26829989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and ethnic disparities in postpartum depression care among low-income women.
    Kozhimannil KB; Trinacty CM; Busch AB; Huskamp HA; Adams AS
    Psychiatr Serv; 2011 Jun; 62(6):619-25. PubMed ID: 21632730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of concomitant use of antipsychotics and stimulants and its impact on stimulant persistence in pediatric attention deficit hyperactivity disorder.
    Bali V; Kamble PS; Aparasu RR
    J Manag Care Spec Pharm; 2015 Jun; 21(6):486-98. PubMed ID: 26011550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.
    Molife C; Bernauer MJ; Farr AM; Haynes VS; Kelsey D
    Postgrad Med; 2012 Sep; 124(5):7-22. PubMed ID: 23095422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.